(Q36622291)

15 August 2017

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials (English)

1 reference

15 August 2017

3

D Zaharevitz

0 references

author name string

J I Johnson

1

1 reference

15 August 2017

S Decker

2

1 reference

15 August 2017

D Zaharevitz

3

1 reference

15 August 2017

L V Rubinstein

4

1 reference

15 August 2017

J M Venditti

5

1 reference

15 August 2017

S Schepartz

6

1 reference

15 August 2017

S Kalyandrug

7

1 reference

15 August 2017

M Christian

8

1 reference

15 August 2017

S Arbuck

9

1 reference

15 August 2017

M Hollingshead

10

1 reference

15 August 2017

E A Sausville

11

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

84

1 reference

15 August 2017

10

1 reference

15 August 2017

1424-1431

1 reference

A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363645

Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USA.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363645

Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363645

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363645

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363645

Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363645

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363645

History of the Cancer Chemotherapy Program

28 June 2018

1 reference

12 December 2020

Preclinical drug development: rationale and methods

1 reference

12 December 2020

Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programs

1 reference

12 December 2020

Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy

1 reference

12 December 2020

Identifiers

DOI

10.1054/BJOC.2001.1796

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

11355958

1 reference